Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

محفوظ في:

التفاصيل البيبلوغرافية
مؤلف مشترك:	Council for International Organizations of Medical Sciences (CIOMS)
التنسيق:	كتاب
اللغة:	English
منشور في:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
الموضوعات:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
الوصول للمادة أونلاين:	Visit NHRC Library
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Martindale: the complete drug reference
بواسطة: Parfitt, Kathleen
منشور في: (1999)

WHO drug information.
منشور في: (2000)

WHO expert committee on specifications for pharmaceutical preparations
منشور في: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
منشور في: (1992)

WHO expert committee on specifications for pharmaceutical preparations
منشور في: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
منشور في: (2012)

USP DI. Approved drug products and legal requirements.
منشور في: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
بواسطة: Andersson, Sarah
منشور في: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
منشور في: (1997)

Pharmacology : a patient-centered nursing process approach /
بواسطة: Kee, Joyce LeFever, وآخرون

Drug calculations : ratio and proportion problems for clinical practice /
بواسطة: Seltzer, Meta Brown, وآخرون

Effective drug regulation a multicountry study /
بواسطة: Ratanawijitrasin, Sauwakon
منشور في: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
بواسطة: DEVS Consult Nepal (P) Ltd.
منشور في: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
بواسطة: Acharya,Kiran
منشور في: (2018)

Regulatory Situation of Herbal Medicines
منشور في: (1998)

A text book of pharmacognosy.
بواسطة: Raut, Bechan, وآخرون
منشور في: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
بواسطة: Adhikari, SM, وآخرون
منشور في: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
منشور في: (2012)

AHFS drug information 2000
بواسطة: Snow, Elaine, K
منشور في: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
منشور في: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
بواسطة: Nepal Health Research Council (NHRC), وآخرون
منشور في: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
بواسطة: Yadav, Raju
منشور في: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
منشور في: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
بواسطة: Brody, Tom
منشور في: (2016)

Evaluation of certain veterinary drug residues in food
منشور في: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
بواسطة: Aryal, BK, وآخرون
منشور في: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
بواسطة: Pande, Sarala
منشور في: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
بواسطة: Adhikari, Shyam Mani
منشور في: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
بواسطة: Adhikari, Shyam Mani, Dr.
منشور في: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
منشور في: (1995)

Fundamentals of Clinical Trials /
بواسطة: Friedman, Lawrence M, وآخرون
منشور في: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
منشور في: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
منشور في: (2000)

Drug policy in the Americas
بواسطة: Smith, Peter H.
منشور في: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
منشور في: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
منشور في: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
بواسطة: Poudel, Krishna Prasad
منشور في: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
بواسطة: Maskay, NM, وآخرون
منشور في: (2016)